Nabi Biopharmaceuticals GlaxoSmithKline Newsletter
-
Nabi Biopharmaceuticals To Receive $5 Million Milestone Payment
12 Dec 2009 00:14 GMT
… 2009 (FinancialWire) — Nabi Biopharmaceuticals (NASDAQ: NABI) announced the initiation … is now owned by GlaxoSmithKline Biologicals .</p … for and has invoiced GSK $5 million for successful … and related assets to GSK. This milestone payment was …
-
CBER-Regulated Products with Supporting Documents
16 Sep 2024 13:13 GMT
… Poliovirus Vaccine Combined
Pediarix
GlaxoSmithKline Biologicals
Diphtheria and Tetanus … Globulin (Human)
Nabi-HB
Nabi Biopharmaceuticals
Hepatitis B Immune Globulin … Virus Vaccine
Fluarix Quadrivalent
GlaxoSmithKline Biologicals
Influenza Virus Vaccine …
-
Licensed Biological Products with Supporting Documents
27 Oct 2022 23:02 GMT
… (Human)
Nabi-HB
Nabi Biopharmaceuticals
Hepatitis B Immune Globulin … Inc.
Fluarix
GlaxoSmithKline Biologicals
Fluarix Quadrivalent
GlaxoSmithKline Biologicals
Flucelvax
… Conjugate Vaccine
MenHibrix
GlaxoSmithKline Biologicals
Meningococcal Polysaccharide …
-
Biopharmaceutical Contract Manufacturing Market to 2025 - Market To Grow At An Annual Rate Of 8.3%, Driven By The Rapidly Expanding Biopharmaceutical Market And Technological Advancements
11 Nov 2015 02:57 GMT
… )
- Genmab
- Gilead
- GlaxoSmithKline Biopharmaceuticals
- Glenmark Pharmaceuticals
- … Transplant
- Nabi Biopharamaceuticals
- Nabi Biopharmaceuticals
- Nascent Biologics, Inc.
- …